News

Filter

Current filters:

OphthalmicsPharmaceutical

1 to 9 of 105 results

NICE gives green light to Bayer’s Eylea for DME

20-02-2015

In a preliminary recommendation issued today, England’s health costs watchdog the National Institute…

BayerEyleaOphthalmicsPharmaceuticalPricingRegulationUK

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

19-02-2015

US biotech Regeneron Pharmaceuticals today announced results from a study which show Eylea (aflibercept)…

AvastinEyleaLucentisOphthalmicsPharmaceuticalRegeneron PharmaceuticalsResearchUSA

Use of generics key to glaucoma medicine adherence, study says

Use of generics key to glaucoma medicine adherence, study says

18-02-2015

A potential solution to resolve patient non-adherence in glaucoma treatment is switching to generic drugs,…

Bimatoprost Ophthalmic Solution 0.03% for GlaLatanoprost OphthalmicOphthalmicsPharmaceuticalPricingResearchUSA

FDA approves Alcon's Pazeo for ocular allergy itch relief

FDA approves Alcon's Pazeo for ocular allergy itch relief

02-02-2015

The US Food and Drug Administration has approved Pazeo (olopatadine hydrochloride ophthalmic solution)…

AlconHealthHealth Medical PharmaNovartisOlopatadine hydrochlorideOphthalmicsPharmaceuticalUSA

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

28-01-2015

Ophthalmic specialist iCura Vision has licensed the intellectual property portfolio and associated research…

iCura VisionLicensingOphthalmicsPharmaceuticalUSA

Nicox holds successful pre-NDA meeting with FDA for AC-170

Nicox holds successful pre-NDA meeting with FDA for AC-170

26-01-2015

French ophthalmics company Nicox has held a positive pre-New Drug Application meeting with the US Food…

AC-170NicOxOphthalmicsPharmaceuticalRegulationUSA

More EMA/CHMP recommendations

23-01-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval…

Anti-viralsAntibiotics and Infectious diseasesCubistDutrebisEuropeIkervisMerck & CoOphthalmicsPharmaceuticalSanten PharmaceuticalsSivextro

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

07-01-2015

Ophthalmic specialist ThromboGenics NV has appointed Dominique Vanfleteren as chief financial officer.

BelgiumBoardroomOphthalmicsPharmaceuticalThromboGenics

1 to 9 of 105 results

Back to top